Robert Meineke

6PUBLICATIONS
13CO-AUTHORS
Medical infection agents (incl. prions)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Horticultural crop protection (incl. pests, diseases and weeds)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 28, 2026
Respiratory syncytial virus-induced ADAM17 activity controls maintenance of epithelial barrier integrity and promotes syncytium formation.

|Jul 13, 2026
iPSC-based macrophage models reveal interferon-dependent control of RSV permissiveness and syncytia formation.

|Apr 27, 2026
Roles of the Chemokine Receptor CX3CR1 in the Pathogenesis of RSV Infections.

|Mar 09, 2026
Induction of a Th1-Type Polyfunctional T-Cell Response by the Four-segmented Rift Valley Fever Candidate Vaccine in Humans.

Amare Aregay, Julia Friese, Sharon Porrez

|Oct 28, 2023
Host Responses to Respiratory Syncytial Virus Infection.

Ayse Agac, Sophie M Kolbe, Martin Ludlow

|Sep 23, 2022
FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections.

Robert Meineke, Sonja Stelz, Maximilian Busch

Pageof 1

Frequent Collaborators

4 joint publications

Martin Ludlow

3 joint publications

Guus F Rimmelzwaan

3 joint publications

Albert D M E Osterhaus

1 joint publications

Sonja Stelz